Riskpilot← Back to searchSign inGet full accessMerck Life Science A/S
A/SActiveCVR 20830131Vandtårnsvej 62A, 5. aWholesale of other machinery and equipment · NACE 4664Est. 199823 employees
Revenue 2024
DKK 1,5B
+10% vs 2023
EBITDA margin
5.5%
-9% vs 2023
Equity ratio
72.6%
Financial strength
Net profit 2024
DKK 66,7M
-9% vs 2023
| Revenue | DKK 1,5B | +10% |
| EBITDA | DKK 85,1M | -9% |
| Net profit | DKK 66,7M | -9% |
| Total assets | DKK 298,3M | -8% |
| Equity | DKK 216,6M | -10% |
| Employees | 23 | — |
Legal name
Merck Life Science A/S
CVR number
20830131
Legal form
Aktieselskab
NACE code
4664 · Wholesale of other machinery and equipment
Founded
20. januar 1998
Share capital
DKK 2.001.000
Employees
23 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening
Company purpose
Selskabets formål er at drive handel samt hermed beslægtet virksomhed.
Address
Vandtårnsvej 62A, 5. a
Phone
+4535253550
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.846 | 25.962 | 27.527 | 34.275 | 20.263 | 21.329 | 26.897 | 53.447 | 768.193 | 1.008.596 | 1.256.087 | 1.398.642 | 1.536.249 |
| Staff expenses | -11.736 | -10.986 | -12.246 | -10.796 | -12.225 | -8.658 | -5.638 | -15.033 | -16.387 | -16.607 | -20.686 | -26.485 | -23.554 |
| EBITDA | 5.395 | 6.029 | 4.428 | 8.768 | 8.038 | 12.670 | 21.259 | 38.414 | 55.709 | 53.145 | 59.439 | 93.268 | 85.098 |
| Depreciation & amort. | -48 | -37 | -16 | -0 | -0 | -0 | -0 | -1.564 | -1.564 | -1.564 | -1.564 | -1.564 | -1.564 |
| EBIT | 5.347 | 5.992 | 4.412 | 8.768 | 8.038 | 12.670 | 21.259 | 36.850 | 54.145 | 51.581 | 57.876 | 91.705 | 83.534 |
| Net financials | 355 | -333 | 747 | 914 | -76 | -1.586 | -118 | -919 | -1.202 | -164 | 365 | 2.949 | 2.535 |
| Profit before tax | 5.702 | 5.659 | 5.159 | 9.683 | 7.962 | 11.085 | 21.141 | 35.931 | 52.943 | 51.417 | 58.240 | 94.653 | 86.069 |
| Tax | 1.429 | 1.422 | 1.274 | 2.277 | 1.757 | 2.440 | 4.432 | 8.544 | 11.667 | 13.694 | 12.239 | 21.043 | 19.339 |
| Net profit | 4.273 | 4.237 | 3.885 | 7.406 | 6.204 | 8.644 | 16.709 | 27.387 | 41.277 | 37.724 | 46.001 | 73.610 | 66.730 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 40.130 | 38.179 | 47.370 | 48.657 | 70.590 | 76.339 | 87.348 | 181.671 | 237.290 | 249.887 | 233.186 | 322.677 | 298.297 |
| Equity | 19.975 | 24.212 | 28.098 | 35.503 | 41.707 | 50.352 | 67.061 | 135.691 | 176.968 | 214.691 | 166.245 | 239.855 | 216.586 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 487 | 1.541 | 0 | 0 | 0 | 22 |
| Short-term debt | 20.155 | 13.967 | 19.273 | 13.154 | 28.882 | 25.987 | 20.287 | 44.773 | 57.908 | 34.164 | 66.248 | 82.634 | 81.689 |
| Total debt | 20.155 | 13.967 | 19.273 | 13.154 | 28.882 | 25.987 | 20.287 | 45.260 | 59.449 | 34.164 | 66.248 | 82.634 | 81.711 |
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
20122024
Equity ratio
72.6%
This company
38.2%
Market median
+90% vs market
20122024
Return on equity
30.8%
This company
18.4%
Market median
+67% vs market
20122024
Net profit margin
4.3%
This company
8.1%
Market median
-47% vs market
20122024
Asset turnover
5.15×
This company
1.12×
Market median
+360% vs market
20122024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Audit | 1998 | — | — | |
LO Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
SH Management | Management | 1998 | — | — |
EÁ Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
JS Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
HC Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
JB Management | Management | 1998 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 1999 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 1998 | — | — | |
| Board of Directors | 1998 | — | — | |
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 | |
| Individual | 100.0% | 100.0% | 2012 | |
| Individual | 100.0% | 100.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Merck Life Science A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Montserrat Jansa Rodriguez | Chief Executive Officer | 0 companies |
| ANDERSEN STATSAUTORISERET REVISIONSAKTIESELSKAB | Audit | 0 companies |
| Lars Ohrberg | Chief Executive Officer | 0 companies |
| Søren Høegh | Management | 0 companies |
| Enrique Álvarez Fernández | Chief Executive Officer | 0 companies |
| Janecke Stokkebokjær Lundring | Chief Executive Officer | 0 companies |
| Hans Christopher Elers Koch | Chief Executive Officer | 0 companies |
| Jørgen Byriel | Management | 0 companies |
| David Mouyal | Chairman | 0 companies |
| Henrik Møgelmose | Board of Directors | 0 companies |
| Franklin Devoe Wicks Jr | Board of Directors | 0 companies |
| Anders Gerner Petersen | Chairman | 0 companies |
| Tom Tallarco | Board of Directors | 0 companies |
| Vagn Thorup | Board of Directors | 0 companies |
| Renée Christine Tunold | Board of Directors | 0 companies |
| Jeanette Sandholmen | Chairman | 0 companies |
| Tiina Marjatta Puhakka | Board of Directors | 0 companies |
| Kurt Skovlund | Board of Directors | 0 companies |
| Michael Egede Budtz | Board of Directors | 0 companies |
| Lutz Schraishuhn | Chairman | 0 companies |